Caris Life Sciences, Inc. (CAI)
CAI Stock Price Chart
Explore Caris Life Sciences, Inc. interactive price chart. Choose custom timeframes to analyze CAI price movements and trends.
CAI Company Profile
Discover essential business fundamentals and corporate details for Caris Life Sciences, Inc. (CAI) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
18 Jun 2025
Employees
1.77K
CEO
David Dean Halbert
Description
Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and machine learning algorithms. The company's molecular profiling services portfolio includes MI Profile, a tissue-based molecular profiling solution; and Caris Assure, a blood-based molecular profiling solution for cancer treatment. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company was founded in 2008 and is headquartered in Irving, Texas.
CAI Financial Timeline
Browse a chronological timeline of Caris Life Sciences, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 12 Aug 2025
EPS came in at -$0.54 falling short of the estimated -$0.21 by -157.14%, while revenue for the quarter reached $181.40M , beating expectations by +31.76%.
CAI Stock Performance
Access detailed CAI performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.